Results of a pilot study with octreotide for patients with hepatocellular carcinoma

被引：0
|
作者：
Stadheim, LM
Hassoun, ZM
Nzeako, UC
Menon, KVN
Talwalkar, JA
LaRusso, NF
Gores, GJ
机构：
来源：
GASTROENTEROLOGY | 2004年 / 126卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A738 / A738
页数：1
相关论文
共 50 条
  • [31] Resection of hepatocellular carcinoma in cirrhotic patients: Longterm results of a prospective study
    Gouillat, C
    Manganas, D
    Saguier, G
    Duque-Campos, R
    Berard, P
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 1999, 189 (03) : 282 - 290
  • [32] Sorafenib in Patients with Hepatocellular Carcinoma-Results of the Observational INSIGHT Study
    Ganten, Tom M.
    Stauber, Rudolf E.
    Schott, Eckardt
    Malfertheiner, Peter
    Buder, Robert
    Galle, Peter R.
    Goehler, Thomas
    Walther, Matthias
    Koschny, Ronald
    Gerken, Guido
    CLINICAL CANCER RESEARCH, 2017, 23 (19) : 5720 - 5728
  • [33] Gefitinib in the adjuvant treatment of hepatocellular carcinoma: A pilot study by the Singapore hepatocellular carcinoma consortium
    Lopes, G.
    Ho, C. K.
    Liau, K. H.
    Chung, A.
    Cheow, P.
    Chang, A. Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [34] Octreotide for improving survival in patients with advanced hepatocellular carcinoma: a meta-analysis
    Estanislao, N. I.
    Ang, E.
    Flores, H.
    Salvana, A.
    Tripon, E.
    Velasquez, M. E.
    Ong, J. P.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A155 - A155
  • [35] Sorafenib plus long-acting octreotide in advanced hepatocellular carcinoma. Preliminary results of a multicenter ongoing study
    Del Prete, S.
    Montella, L.
    Addeo, R.
    Maiorino, L.
    Montesarchio, V.
    Cennamo, G.
    Leo, G.
    Palmieri, G.
    Bianco, M.
    Caraglia, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [36] SORAFENIB PLUS LONG-ACTING OCTREOTIDE IN ADVANCED HEPATOCELLULAR CARCINOMA. PRELIMINARY RESULTS OF A MULTICENTER ONGOING STUDY
    Del Prete, S.
    Addeo, R.
    Maiorino, L.
    Cennamo, G.
    Montesarchio, V.
    Leo, L.
    Faiola, V.
    Guarrasi, R.
    Tarantino, L.
    Vascone, A.
    D'Agostino, A.
    Palmieri, G.
    Bianco, M.
    Caraglia, M.
    Pizza, C.
    Mamone, R.
    Montella, L.
    EJC SUPPLEMENTS, 2008, 6 (14): : 119 - 120
  • [37] Efficacy of long acting release octreotide in patients with advanced hepatocellular carcinoma: A randomized multicenter phase III study
    Verslype, C.
    Verset, G.
    Reynaert, H.
    Borbath, I.
    Langlet, P.
    Vandebroek, A.
    Peeters, M.
    Houbiers, G.
    Michielsen, P.
    Arvanitaki, M.
    Van Laethem, J. L.
    JOURNAL OF HEPATOLOGY, 2006, 44 : S110 - S110
  • [38] Efficacy of long acting release octreotide in patients with advanced hepatocellular carcinoma: A randomized multicenter phase III study
    Verset, Gontran
    Verslype, Chris
    Reynaert, Hendrik
    Borbath, Ivan
    Langlet, Philippe
    van den Brouck, Ann
    Peeters, Marc
    Houbiers, Gluslain
    Michielsen, Peeter
    Arvanitakis, Marianna
    van Laethem, Jean-Luc
    GASTROENTEROLOGY, 2006, 130 (04) : A497 - A498
  • [39] ZOLEDRONIC ACID PLUS SORAFENIB AND OCTREOTIDE IN HEPATOCELLULAR CARCINOMA WITH BONE METASTASES: RESULTS OF A SUBGROUP ANALYSIS
    Del Prete, Salvatore
    Montella, Liliana
    Caraglia, Michele
    Leopardo, Davide
    Cennamo, Gregorio
    Mamone, Rosanna
    Guarrasi, Rosario
    Iodice, Patrizia
    D'Agostino, Alberto
    Vincenzi, Bruno
    Maiorino, Luigi
    Pizza, Carmine
    Montesarchio, Vincenzo
    Faiola, Vincenzo
    Addeo, Raffaele
    ANNALS OF ONCOLOGY, 2009, 20
  • [40] Sonic hedgehog signaling in hepatocellular carcinoma: A pilot study
    Dugum, Mohannad
    Hanouneh, Ibrahim
    McIntyre, Thomas
    Pai, Rish
    Aucejo, Federico
    Eghtesad, Bijan
    Zein, Nizar
    MOLECULAR AND CLINICAL ONCOLOGY, 2016, 4 (03) : 369 - 374
12345